Streetbeat News

Analyst Ratings

KBR

KBR (NYSE:KBR) has received positive analyst ratings in the last quarter, with 4 bullish and 1 somewhat bullish ratings. The average 12-month price target for KBR has increased by 7.41% from the previous average, now standing at $75.4.

Portfolio Pulse from Benzinga Insights

September 06, 2023 | 8:00 pm

NVO

A significant bearish stance has been taken on Novo Nordisk (NYSE:NVO) by a large investor, as observed in the unusual options activity. The overall sentiment of these big-money traders is split between 46% bullish and 53% bearish. The whales have been targeting a price range from $170.0 to $220.0 for Novo Nordisk over the last 3 months. The price of NVO is up 0.77% at $191.57, with RSI indicators hinting at an overbought situation.

Portfolio Pulse from Benzinga Insights

September 06, 2023 | 7:47 pm

CVX

A significant bearish stance has been taken on Chevron (NYSE:CVX) by a large investor, as observed in the publicly available options history. The overall sentiment of these big-money traders is split between 23% bullish and 76% bearish. The whales have been targeting a price range from $130.0 to $200.0 for Chevron over the last 3 months. The price of CVX is up 0.36% at $167.06, with RSI indicators hinting at an overbought situation.

Portfolio Pulse from Benzinga Insights

September 06, 2023 | 7:31 pm

XOM

Exxon Mobil (NYSE:XOM) has seen unusual options activity, with a significant number of bullish trades. Of the 12 strange trades detected, 58% were bullish and 41% bearish. The total amount for puts was $86,475 and for calls was $476,530. Whales have been targeting a price range from $110.0 to $130.0 for Exxon Mobil over the last 3 months. The current price of XOM is up 0.7% at $114.32. Analysts from Morgan Stanley, Redburn Partners, Mizuho, and UBS have maintained their ratings on Exxon Mobil with price targets ranging from $105 to $139.

Portfolio Pulse from Benzinga Insights

September 06, 2023 | 7:31 pm

SEDG

Morgan Stanley has maintained an Equal-Weight rating on SolarEdge's stock but lowered its price target from $334 to $240. This has led to a decrease in SolarEdge's share price.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 7:25 pm

XPOF

Xponential Fitness has issued three-year operating targets ahead of its analyst and investor day, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 7:19 pm

LMAT

Oppenheimer has initiated coverage on LeMaitre Vascular Inc (NASDAQ:LMAT) with an Outperform rating and a price target of $70. The company generates 90% of its sales from a third of its core markets, and its products are used by 11,000 vascular surgeons from 4,800 hospitals. LMAT's growth strategy includes smaller strategic acquisitions, with a successful track record of securing 70% of their 24 acquisition endeavors over the past 20 years.

Portfolio Pulse from Vandana Singh

September 06, 2023 | 7:04 pm

PAA

Plains All American's stock has been downgraded from Buy to Neutral by Citigroup, leading to a decrease in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 7:01 pm

TVTX

Analysts have provided various ratings for Travere Therapeutics (NASDAQ:TVTX) within the last quarter, with 2 bullish, 3 somewhat bullish, and 1 indifferent. The average 12-month price target for the company is $27.5, a decrease of 12.22% from the previous average price target of $31.33.

Portfolio Pulse from Benzinga Insights

September 06, 2023 | 7:00 pm

LSXMK

Analysts have provided ratings for Liberty SiriusXM Gr (NASDAQ:LSXMK) within the last quarter. The ratings include 1 bullish and 3 indifferent. The average price target is $34.75, implying an upside from the current price of $23.66. This average has decreased by 11.46% from the previous average price target of $39.25.

Portfolio Pulse from Benzinga Insights

September 06, 2023 | 7:00 pm